nodes	percent_of_prediction	percent_of_DWPC	metapath
Vinorelbine—ABCB1—Lisinopril—systemic scleroderma	0.0861	0.228	CbGbCtD
Vinorelbine—ABCB1—Captopril—systemic scleroderma	0.0645	0.171	CbGbCtD
Vinorelbine—CYP2D6—Captopril—systemic scleroderma	0.0607	0.161	CbGbCtD
Vinorelbine—ABCB1—Mycophenolate mofetil—systemic scleroderma	0.0508	0.134	CbGbCtD
Vinorelbine—ABCB1—Prednisone—systemic scleroderma	0.0406	0.107	CbGbCtD
Vinorelbine—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.0304	0.0805	CbGbCtD
Vinorelbine—CYP3A4—Prednisone—systemic scleroderma	0.0243	0.0644	CbGbCtD
Vinorelbine—ABCB1—Methotrexate—systemic scleroderma	0.0204	0.0539	CbGbCtD
Vinorelbine—TUBB3—connective tissue—systemic scleroderma	0.00652	0.0645	CbGeAlD
Vinorelbine—TUBB3—digestive system—systemic scleroderma	0.00471	0.0466	CbGeAlD
Vinorelbine—TUBB4A—connective tissue—systemic scleroderma	0.00397	0.0393	CbGeAlD
Vinorelbine—TUBB3—lung—systemic scleroderma	0.00393	0.0389	CbGeAlD
Vinorelbine—TUBB2B—connective tissue—systemic scleroderma	0.00383	0.038	CbGeAlD
Vinorelbine—TUBB2A—connective tissue—systemic scleroderma	0.00361	0.0357	CbGeAlD
Vinorelbine—TUBB4A—skin of body—systemic scleroderma	0.00358	0.0355	CbGeAlD
Vinorelbine—TUBB—smooth muscle tissue—systemic scleroderma	0.00332	0.0329	CbGeAlD
Vinorelbine—TUBB2A—smooth muscle tissue—systemic scleroderma	0.0033	0.0327	CbGeAlD
Vinorelbine—TUBB2A—skin of body—systemic scleroderma	0.00326	0.0323	CbGeAlD
Vinorelbine—TUBB6—smooth muscle tissue—systemic scleroderma	0.00326	0.0322	CbGeAlD
Vinorelbine—TUBB6—skin of body—systemic scleroderma	0.00321	0.0318	CbGeAlD
Vinorelbine—TUBB4B—connective tissue—systemic scleroderma	0.00309	0.0306	CbGeAlD
Vinorelbine—TUBB4A—digestive system—systemic scleroderma	0.00286	0.0284	CbGeAlD
Vinorelbine—TUBB4B—smooth muscle tissue—systemic scleroderma	0.00283	0.028	CbGeAlD
Vinorelbine—TUBB4B—skin of body—systemic scleroderma	0.00279	0.0277	CbGeAlD
Vinorelbine—TUBB2B—digestive system—systemic scleroderma	0.00277	0.0274	CbGeAlD
Vinorelbine—TUBB4A—tendon—systemic scleroderma	0.00273	0.027	CbGeAlD
Vinorelbine—TUBB2B—tendon—systemic scleroderma	0.00263	0.0261	CbGeAlD
Vinorelbine—TUBB2A—digestive system—systemic scleroderma	0.00261	0.0258	CbGeAlD
Vinorelbine—TUBB6—digestive system—systemic scleroderma	0.00257	0.0255	CbGeAlD
Vinorelbine—TUBB—tendon—systemic scleroderma	0.00249	0.0247	CbGeAlD
Vinorelbine—TUBB2A—tendon—systemic scleroderma	0.00248	0.0246	CbGeAlD
Vinorelbine—TUBB6—tendon—systemic scleroderma	0.00245	0.0242	CbGeAlD
Vinorelbine—TUBB4A—lung—systemic scleroderma	0.00239	0.0237	CbGeAlD
Vinorelbine—TUBB2B—lung—systemic scleroderma	0.00231	0.0229	CbGeAlD
Vinorelbine—TUBB4B—digestive system—systemic scleroderma	0.00223	0.0221	CbGeAlD
Vinorelbine—TUBB—lung—systemic scleroderma	0.00219	0.0217	CbGeAlD
Vinorelbine—TUBB2A—lung—systemic scleroderma	0.00218	0.0216	CbGeAlD
Vinorelbine—TUBB6—lung—systemic scleroderma	0.00215	0.0213	CbGeAlD
Vinorelbine—TUBB4B—tendon—systemic scleroderma	0.00213	0.0211	CbGeAlD
Vinorelbine—TUBB4B—lung—systemic scleroderma	0.00187	0.0185	CbGeAlD
Vinorelbine—ABCB1—blood vessel—systemic scleroderma	0.00175	0.0174	CbGeAlD
Vinorelbine—CYP3A4—digestive system—systemic scleroderma	0.000918	0.00909	CbGeAlD
Vinorelbine—CYP2D6—digestive system—systemic scleroderma	0.000903	0.00894	CbGeAlD
Vinorelbine—ABCB1—digestive system—systemic scleroderma	0.00065	0.00643	CbGeAlD
Vinorelbine—ABCB1—lung—systemic scleroderma	0.000543	0.00537	CbGeAlD
Vinorelbine—Cerebrovascular accident—Methotrexate—systemic scleroderma	0.000525	0.00101	CcSEcCtD
Vinorelbine—Lethargy—Methotrexate—systemic scleroderma	0.000525	0.00101	CcSEcCtD
Vinorelbine—Pancreatitis—Prednisone—systemic scleroderma	0.000522	0.001	CcSEcCtD
Vinorelbine—Vomiting—Mometasone—systemic scleroderma	0.000521	0.000999	CcSEcCtD
Vinorelbine—Feeling abnormal—Azathioprine—systemic scleroderma	0.000517	0.000993	CcSEcCtD
Vinorelbine—Rash—Mometasone—systemic scleroderma	0.000517	0.000991	CcSEcCtD
Vinorelbine—Asthenia—Captopril—systemic scleroderma	0.000516	0.00099	CcSEcCtD
Vinorelbine—Dermatitis—Mometasone—systemic scleroderma	0.000516	0.00099	CcSEcCtD
Vinorelbine—Decreased appetite—Leflunomide—systemic scleroderma	0.000515	0.000989	CcSEcCtD
Vinorelbine—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.000515	0.000989	CcSEcCtD
Vinorelbine—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.000513	0.000985	CcSEcCtD
Vinorelbine—Headache—Mometasone—systemic scleroderma	0.000513	0.000984	CcSEcCtD
Vinorelbine—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.000512	0.000982	CcSEcCtD
Vinorelbine—Fatigue—Leflunomide—systemic scleroderma	0.000511	0.000981	CcSEcCtD
Vinorelbine—Anaphylactic shock—Lisinopril—systemic scleroderma	0.00051	0.000977	CcSEcCtD
Vinorelbine—Pruritus—Captopril—systemic scleroderma	0.000509	0.000976	CcSEcCtD
Vinorelbine—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.000508	0.000974	CcSEcCtD
Vinorelbine—Ill-defined disorder—Mycophenolate mofetil—systemic scleroderma	0.000508	0.000974	CcSEcCtD
Vinorelbine—Constipation—Leflunomide—systemic scleroderma	0.000507	0.000973	CcSEcCtD
Vinorelbine—Pain—Leflunomide—systemic scleroderma	0.000507	0.000973	CcSEcCtD
Vinorelbine—Infection—Lisinopril—systemic scleroderma	0.000506	0.000971	CcSEcCtD
Vinorelbine—Anaemia—Mycophenolate mofetil—systemic scleroderma	0.000506	0.00097	CcSEcCtD
Vinorelbine—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.000504	0.000967	CcSEcCtD
Vinorelbine—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.0005	0.000959	CcSEcCtD
Vinorelbine—Thrombocytopenia—Lisinopril—systemic scleroderma	0.000499	0.000957	CcSEcCtD
Vinorelbine—Neutropenia—Prednisone—systemic scleroderma	0.000498	0.000955	CcSEcCtD
Vinorelbine—Tachycardia—Lisinopril—systemic scleroderma	0.000497	0.000954	CcSEcCtD
Vinorelbine—Abdominal pain—Azathioprine—systemic scleroderma	0.000496	0.000952	CcSEcCtD
Vinorelbine—Body temperature increased—Azathioprine—systemic scleroderma	0.000496	0.000952	CcSEcCtD
Vinorelbine—Skin disorder—Lisinopril—systemic scleroderma	0.000495	0.000949	CcSEcCtD
Vinorelbine—Malaise—Mycophenolate mofetil—systemic scleroderma	0.000493	0.000946	CcSEcCtD
Vinorelbine—Diarrhoea—Captopril—systemic scleroderma	0.000492	0.000944	CcSEcCtD
Vinorelbine—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000492	0.000943	CcSEcCtD
Vinorelbine—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.000491	0.000943	CcSEcCtD
Vinorelbine—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.00049	0.000939	CcSEcCtD
Vinorelbine—Feeling abnormal—Leflunomide—systemic scleroderma	0.000489	0.000937	CcSEcCtD
Vinorelbine—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000488	0.000937	CcSEcCtD
Vinorelbine—Fatigue—Mycophenolic acid—systemic scleroderma	0.000488	0.000936	CcSEcCtD
Vinorelbine—Nausea—Mometasone—systemic scleroderma	0.000487	0.000933	CcSEcCtD
Vinorelbine—Anorexia—Lisinopril—systemic scleroderma	0.000486	0.000932	CcSEcCtD
Vinorelbine—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000485	0.00093	CcSEcCtD
Vinorelbine—Pain—Mycophenolic acid—systemic scleroderma	0.000484	0.000928	CcSEcCtD
Vinorelbine—Constipation—Mycophenolic acid—systemic scleroderma	0.000484	0.000928	CcSEcCtD
Vinorelbine—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.000483	0.000927	CcSEcCtD
Vinorelbine—Weight decreased—Prednisone—systemic scleroderma	0.000481	0.000924	CcSEcCtD
Vinorelbine—Cough—Mycophenolate mofetil—systemic scleroderma	0.000477	0.000916	CcSEcCtD
Vinorelbine—Hypotension—Lisinopril—systemic scleroderma	0.000476	0.000913	CcSEcCtD
Vinorelbine—Dizziness—Captopril—systemic scleroderma	0.000476	0.000913	CcSEcCtD
Vinorelbine—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.000472	0.000906	CcSEcCtD
Vinorelbine—Urticaria—Leflunomide—systemic scleroderma	0.000471	0.000904	CcSEcCtD
Vinorelbine—Abdominal pain—Leflunomide—systemic scleroderma	0.000469	0.000899	CcSEcCtD
Vinorelbine—Body temperature increased—Leflunomide—systemic scleroderma	0.000469	0.000899	CcSEcCtD
Vinorelbine—Acute coronary syndrome—Prednisone—systemic scleroderma	0.000468	0.000897	CcSEcCtD
Vinorelbine—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000466	0.000894	CcSEcCtD
Vinorelbine—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.000466	0.000893	CcSEcCtD
Vinorelbine—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.000466	0.000893	CcSEcCtD
Vinorelbine—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.000466	0.000893	CcSEcCtD
Vinorelbine—Myocardial infarction—Prednisone—systemic scleroderma	0.000465	0.000892	CcSEcCtD
Vinorelbine—Neuropathy peripheral—Prednisone—systemic scleroderma	0.000465	0.000892	CcSEcCtD
Vinorelbine—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000464	0.000891	CcSEcCtD
Vinorelbine—Hypersensitivity—Azathioprine—systemic scleroderma	0.000463	0.000887	CcSEcCtD
Vinorelbine—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000463	0.000887	CcSEcCtD
Vinorelbine—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.000462	0.000887	CcSEcCtD
Vinorelbine—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.00046	0.000883	CcSEcCtD
Vinorelbine—Paraesthesia—Lisinopril—systemic scleroderma	0.000458	0.000878	CcSEcCtD
Vinorelbine—Vomiting—Captopril—systemic scleroderma	0.000457	0.000878	CcSEcCtD
Vinorelbine—Dyspnoea—Lisinopril—systemic scleroderma	0.000454	0.000871	CcSEcCtD
Vinorelbine—Rash—Captopril—systemic scleroderma	0.000454	0.00087	CcSEcCtD
Vinorelbine—Dermatitis—Captopril—systemic scleroderma	0.000453	0.000869	CcSEcCtD
Vinorelbine—Headache—Captopril—systemic scleroderma	0.000451	0.000865	CcSEcCtD
Vinorelbine—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000447	0.000858	CcSEcCtD
Vinorelbine—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000447	0.000858	CcSEcCtD
Vinorelbine—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.000446	0.000856	CcSEcCtD
Vinorelbine—Infection—Mycophenolate mofetil—systemic scleroderma	0.000444	0.000851	CcSEcCtD
Vinorelbine—Decreased appetite—Lisinopril—systemic scleroderma	0.000443	0.00085	CcSEcCtD
Vinorelbine—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.00044	0.000844	CcSEcCtD
Vinorelbine—Fatigue—Lisinopril—systemic scleroderma	0.000439	0.000843	CcSEcCtD
Vinorelbine—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000438	0.00084	CcSEcCtD
Vinorelbine—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000437	0.000839	CcSEcCtD
Vinorelbine—Hypersensitivity—Leflunomide—systemic scleroderma	0.000437	0.000838	CcSEcCtD
Vinorelbine—Pancreatitis—Methotrexate—systemic scleroderma	0.000436	0.000836	CcSEcCtD
Vinorelbine—Constipation—Lisinopril—systemic scleroderma	0.000436	0.000836	CcSEcCtD
Vinorelbine—Pain—Lisinopril—systemic scleroderma	0.000436	0.000836	CcSEcCtD
Vinorelbine—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000436	0.000836	CcSEcCtD
Vinorelbine—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000434	0.000832	CcSEcCtD
Vinorelbine—Diarrhoea—Azathioprine—systemic scleroderma	0.00043	0.000824	CcSEcCtD
Vinorelbine—Nausea—Captopril—systemic scleroderma	0.000427	0.00082	CcSEcCtD
Vinorelbine—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000426	0.000816	CcSEcCtD
Vinorelbine—Asthenia—Leflunomide—systemic scleroderma	0.000425	0.000816	CcSEcCtD
Vinorelbine—Pancytopenia—Methotrexate—systemic scleroderma	0.000422	0.00081	CcSEcCtD
Vinorelbine—Feeling abnormal—Lisinopril—systemic scleroderma	0.00042	0.000805	CcSEcCtD
Vinorelbine—Pruritus—Leflunomide—systemic scleroderma	0.00042	0.000805	CcSEcCtD
Vinorelbine—Connective tissue disorder—Prednisone—systemic scleroderma	0.000419	0.000803	CcSEcCtD
Vinorelbine—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000417	0.0008	CcSEcCtD
Vinorelbine—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000417	0.000799	CcSEcCtD
Vinorelbine—Neutropenia—Methotrexate—systemic scleroderma	0.000416	0.000798	CcSEcCtD
Vinorelbine—Dizziness—Azathioprine—systemic scleroderma	0.000415	0.000797	CcSEcCtD
Vinorelbine—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000407	0.00078	CcSEcCtD
Vinorelbine—Asthenia—Mycophenolic acid—systemic scleroderma	0.000406	0.000779	CcSEcCtD
Vinorelbine—Diarrhoea—Leflunomide—systemic scleroderma	0.000406	0.000778	CcSEcCtD
Vinorelbine—Urticaria—Lisinopril—systemic scleroderma	0.000405	0.000776	CcSEcCtD
Vinorelbine—Body temperature increased—Lisinopril—systemic scleroderma	0.000403	0.000773	CcSEcCtD
Vinorelbine—Abdominal pain—Lisinopril—systemic scleroderma	0.000403	0.000773	CcSEcCtD
Vinorelbine—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000401	0.000769	CcSEcCtD
Vinorelbine—Pruritus—Mycophenolic acid—systemic scleroderma	0.0004	0.000768	CcSEcCtD
Vinorelbine—Vomiting—Azathioprine—systemic scleroderma	0.000399	0.000766	CcSEcCtD
Vinorelbine—Pneumonia—Methotrexate—systemic scleroderma	0.000399	0.000765	CcSEcCtD
Vinorelbine—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000398	0.000764	CcSEcCtD
Vinorelbine—Infestation NOS—Methotrexate—systemic scleroderma	0.000397	0.000761	CcSEcCtD
Vinorelbine—Infestation—Methotrexate—systemic scleroderma	0.000397	0.000761	CcSEcCtD
Vinorelbine—Rash—Azathioprine—systemic scleroderma	0.000396	0.000759	CcSEcCtD
Vinorelbine—Dermatitis—Azathioprine—systemic scleroderma	0.000396	0.000759	CcSEcCtD
Vinorelbine—Flushing—Prednisone—systemic scleroderma	0.000395	0.000758	CcSEcCtD
Vinorelbine—Headache—Azathioprine—systemic scleroderma	0.000393	0.000755	CcSEcCtD
Vinorelbine—Dizziness—Leflunomide—systemic scleroderma	0.000392	0.000752	CcSEcCtD
Vinorelbine—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000388	0.000744	CcSEcCtD
Vinorelbine—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000387	0.000742	CcSEcCtD
Vinorelbine—Stomatitis—Methotrexate—systemic scleroderma	0.000387	0.000741	CcSEcCtD
Vinorelbine—Angiopathy—Prednisone—systemic scleroderma	0.000386	0.000741	CcSEcCtD
Vinorelbine—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000385	0.000739	CcSEcCtD
Vinorelbine—Immune system disorder—Prednisone—systemic scleroderma	0.000385	0.000738	CcSEcCtD
Vinorelbine—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000382	0.000732	CcSEcCtD
Vinorelbine—Pain—Mycophenolate mofetil—systemic scleroderma	0.000382	0.000732	CcSEcCtD
Vinorelbine—Arrhythmia—Prednisone—systemic scleroderma	0.000381	0.00073	CcSEcCtD
Vinorelbine—Vomiting—Leflunomide—systemic scleroderma	0.000377	0.000723	CcSEcCtD
Vinorelbine—Alopecia—Prednisone—systemic scleroderma	0.000376	0.000722	CcSEcCtD
Vinorelbine—Hypersensitivity—Lisinopril—systemic scleroderma	0.000375	0.00072	CcSEcCtD
Vinorelbine—Hepatobiliary disease—Methotrexate—systemic scleroderma	0.000375	0.000719	CcSEcCtD
Vinorelbine—Dizziness—Mycophenolic acid—systemic scleroderma	0.000374	0.000718	CcSEcCtD
Vinorelbine—Rash—Leflunomide—systemic scleroderma	0.000374	0.000717	CcSEcCtD
Vinorelbine—Dermatitis—Leflunomide—systemic scleroderma	0.000374	0.000717	CcSEcCtD
Vinorelbine—Nausea—Azathioprine—systemic scleroderma	0.000373	0.000715	CcSEcCtD
Vinorelbine—Headache—Leflunomide—systemic scleroderma	0.000371	0.000713	CcSEcCtD
Vinorelbine—Erythema—Prednisone—systemic scleroderma	0.000371	0.000711	CcSEcCtD
Vinorelbine—Malnutrition—Prednisone—systemic scleroderma	0.000371	0.000711	CcSEcCtD
Vinorelbine—Agranulocytosis—Methotrexate—systemic scleroderma	0.00037	0.00071	CcSEcCtD
Vinorelbine—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000368	0.000706	CcSEcCtD
Vinorelbine—Asthenia—Lisinopril—systemic scleroderma	0.000366	0.000701	CcSEcCtD
Vinorelbine—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000365	0.0007	CcSEcCtD
Vinorelbine—Pruritus—Lisinopril—systemic scleroderma	0.00036	0.000692	CcSEcCtD
Vinorelbine—Vomiting—Mycophenolic acid—systemic scleroderma	0.00036	0.00069	CcSEcCtD
Vinorelbine—Rash—Mycophenolic acid—systemic scleroderma	0.000357	0.000684	CcSEcCtD
Vinorelbine—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000356	0.000684	CcSEcCtD
Vinorelbine—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000355	0.00068	CcSEcCtD
Vinorelbine—Headache—Mycophenolic acid—systemic scleroderma	0.000354	0.00068	CcSEcCtD
Vinorelbine—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000353	0.000677	CcSEcCtD
Vinorelbine—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000353	0.000677	CcSEcCtD
Vinorelbine—Nausea—Leflunomide—systemic scleroderma	0.000352	0.000676	CcSEcCtD
Vinorelbine—Diarrhoea—Lisinopril—systemic scleroderma	0.000349	0.000669	CcSEcCtD
Vinorelbine—Ill-defined disorder—Prednisone—systemic scleroderma	0.000344	0.00066	CcSEcCtD
Vinorelbine—Anaemia—Prednisone—systemic scleroderma	0.000343	0.000657	CcSEcCtD
Vinorelbine—Angioedema—Prednisone—systemic scleroderma	0.000339	0.00065	CcSEcCtD
Vinorelbine—Dizziness—Lisinopril—systemic scleroderma	0.000337	0.000646	CcSEcCtD
Vinorelbine—Nausea—Mycophenolic acid—systemic scleroderma	0.000336	0.000645	CcSEcCtD
Vinorelbine—Malaise—Prednisone—systemic scleroderma	0.000334	0.000641	CcSEcCtD
Vinorelbine—Vertigo—Prednisone—systemic scleroderma	0.000333	0.000639	CcSEcCtD
Vinorelbine—Cardiac disorder—Methotrexate—systemic scleroderma	0.00033	0.000634	CcSEcCtD
Vinorelbine—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000329	0.000631	CcSEcCtD
Vinorelbine—Vomiting—Lisinopril—systemic scleroderma	0.000324	0.000621	CcSEcCtD
Vinorelbine—Angiopathy—Methotrexate—systemic scleroderma	0.000323	0.00062	CcSEcCtD
Vinorelbine—Immune system disorder—Methotrexate—systemic scleroderma	0.000322	0.000617	CcSEcCtD
Vinorelbine—Rash—Lisinopril—systemic scleroderma	0.000321	0.000616	CcSEcCtD
Vinorelbine—Dermatitis—Lisinopril—systemic scleroderma	0.000321	0.000616	CcSEcCtD
Vinorelbine—Mediastinal disorder—Methotrexate—systemic scleroderma	0.000321	0.000615	CcSEcCtD
Vinorelbine—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.00032	0.000614	CcSEcCtD
Vinorelbine—Hypertension—Prednisone—systemic scleroderma	0.00032	0.000614	CcSEcCtD
Vinorelbine—Headache—Lisinopril—systemic scleroderma	0.000319	0.000612	CcSEcCtD
Vinorelbine—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000316	0.000606	CcSEcCtD
Vinorelbine—Arthralgia—Prednisone—systemic scleroderma	0.000316	0.000606	CcSEcCtD
Vinorelbine—Myalgia—Prednisone—systemic scleroderma	0.000316	0.000606	CcSEcCtD
Vinorelbine—Alopecia—Methotrexate—systemic scleroderma	0.000315	0.000603	CcSEcCtD
Vinorelbine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.000314	0.000601	CcSEcCtD
Vinorelbine—Discomfort—Prednisone—systemic scleroderma	0.000312	0.000598	CcSEcCtD
Vinorelbine—Erythema—Methotrexate—systemic scleroderma	0.00031	0.000594	CcSEcCtD
Vinorelbine—Malnutrition—Methotrexate—systemic scleroderma	0.00031	0.000594	CcSEcCtD
Vinorelbine—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000305	0.000586	CcSEcCtD
Vinorelbine—Nausea—Lisinopril—systemic scleroderma	0.000303	0.000581	CcSEcCtD
Vinorelbine—Anaphylactic shock—Prednisone—systemic scleroderma	0.000303	0.000581	CcSEcCtD
Vinorelbine—Infection—Prednisone—systemic scleroderma	0.000301	0.000577	CcSEcCtD
Vinorelbine—Back pain—Methotrexate—systemic scleroderma	0.0003	0.000575	CcSEcCtD
Vinorelbine—Nervous system disorder—Prednisone—systemic scleroderma	0.000297	0.000569	CcSEcCtD
Vinorelbine—Tachycardia—Prednisone—systemic scleroderma	0.000295	0.000567	CcSEcCtD
Vinorelbine—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000295	0.000566	CcSEcCtD
Vinorelbine—Skin disorder—Prednisone—systemic scleroderma	0.000294	0.000564	CcSEcCtD
Vinorelbine—Anorexia—Prednisone—systemic scleroderma	0.000288	0.000553	CcSEcCtD
Vinorelbine—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000288	0.000552	CcSEcCtD
Vinorelbine—Anaemia—Methotrexate—systemic scleroderma	0.000286	0.000549	CcSEcCtD
Vinorelbine—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000284	0.000545	CcSEcCtD
Vinorelbine—Rash—Mycophenolate mofetil—systemic scleroderma	0.000281	0.00054	CcSEcCtD
Vinorelbine—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000281	0.000539	CcSEcCtD
Vinorelbine—Headache—Mycophenolate mofetil—systemic scleroderma	0.00028	0.000537	CcSEcCtD
Vinorelbine—Malaise—Methotrexate—systemic scleroderma	0.000279	0.000536	CcSEcCtD
Vinorelbine—Vertigo—Methotrexate—systemic scleroderma	0.000278	0.000534	CcSEcCtD
Vinorelbine—Leukopenia—Methotrexate—systemic scleroderma	0.000277	0.000532	CcSEcCtD
Vinorelbine—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000276	0.000529	CcSEcCtD
Vinorelbine—Paraesthesia—Prednisone—systemic scleroderma	0.000272	0.000521	CcSEcCtD
Vinorelbine—Cough—Methotrexate—systemic scleroderma	0.00027	0.000519	CcSEcCtD
Vinorelbine—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000265	0.000509	CcSEcCtD
Vinorelbine—Chest pain—Methotrexate—systemic scleroderma	0.000264	0.000506	CcSEcCtD
Vinorelbine—Arthralgia—Methotrexate—systemic scleroderma	0.000264	0.000506	CcSEcCtD
Vinorelbine—Myalgia—Methotrexate—systemic scleroderma	0.000264	0.000506	CcSEcCtD
Vinorelbine—Decreased appetite—Prednisone—systemic scleroderma	0.000263	0.000505	CcSEcCtD
Vinorelbine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.000262	0.000503	CcSEcCtD
Vinorelbine—Fatigue—Prednisone—systemic scleroderma	0.000261	0.0005	CcSEcCtD
Vinorelbine—Discomfort—Methotrexate—systemic scleroderma	0.000261	0.0005	CcSEcCtD
Vinorelbine—Constipation—Prednisone—systemic scleroderma	0.000259	0.000496	CcSEcCtD
Vinorelbine—Anaphylactic shock—Methotrexate—systemic scleroderma	0.000253	0.000485	CcSEcCtD
Vinorelbine—Infection—Methotrexate—systemic scleroderma	0.000251	0.000482	CcSEcCtD
Vinorelbine—Feeling abnormal—Prednisone—systemic scleroderma	0.000249	0.000478	CcSEcCtD
Vinorelbine—Nervous system disorder—Methotrexate—systemic scleroderma	0.000248	0.000476	CcSEcCtD
Vinorelbine—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000248	0.000475	CcSEcCtD
Vinorelbine—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000247	0.000475	CcSEcCtD
Vinorelbine—Skin disorder—Methotrexate—systemic scleroderma	0.000246	0.000471	CcSEcCtD
Vinorelbine—Anorexia—Methotrexate—systemic scleroderma	0.000241	0.000462	CcSEcCtD
Vinorelbine—Urticaria—Prednisone—systemic scleroderma	0.00024	0.000461	CcSEcCtD
Vinorelbine—Body temperature increased—Prednisone—systemic scleroderma	0.000239	0.000459	CcSEcCtD
Vinorelbine—Abdominal pain—Prednisone—systemic scleroderma	0.000239	0.000459	CcSEcCtD
Vinorelbine—Hypotension—Methotrexate—systemic scleroderma	0.000236	0.000453	CcSEcCtD
Vinorelbine—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.00023	0.000442	CcSEcCtD
Vinorelbine—Paraesthesia—Methotrexate—systemic scleroderma	0.000227	0.000436	CcSEcCtD
Vinorelbine—Dyspnoea—Methotrexate—systemic scleroderma	0.000225	0.000433	CcSEcCtD
Vinorelbine—Hypersensitivity—Prednisone—systemic scleroderma	0.000223	0.000428	CcSEcCtD
Vinorelbine—Decreased appetite—Methotrexate—systemic scleroderma	0.00022	0.000422	CcSEcCtD
Vinorelbine—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000218	0.000419	CcSEcCtD
Vinorelbine—Fatigue—Methotrexate—systemic scleroderma	0.000218	0.000418	CcSEcCtD
Vinorelbine—Asthenia—Prednisone—systemic scleroderma	0.000217	0.000416	CcSEcCtD
Vinorelbine—Pain—Methotrexate—systemic scleroderma	0.000216	0.000415	CcSEcCtD
Vinorelbine—Pruritus—Prednisone—systemic scleroderma	0.000214	0.000411	CcSEcCtD
Vinorelbine—Feeling abnormal—Methotrexate—systemic scleroderma	0.000208	0.0004	CcSEcCtD
Vinorelbine—Diarrhoea—Prednisone—systemic scleroderma	0.000207	0.000397	CcSEcCtD
Vinorelbine—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000207	0.000397	CcSEcCtD
Vinorelbine—Urticaria—Methotrexate—systemic scleroderma	0.000201	0.000385	CcSEcCtD
Vinorelbine—Dizziness—Prednisone—systemic scleroderma	0.0002	0.000384	CcSEcCtD
Vinorelbine—Abdominal pain—Methotrexate—systemic scleroderma	0.0002	0.000384	CcSEcCtD
Vinorelbine—Body temperature increased—Methotrexate—systemic scleroderma	0.0002	0.000384	CcSEcCtD
Vinorelbine—Vomiting—Prednisone—systemic scleroderma	0.000192	0.000369	CcSEcCtD
Vinorelbine—Rash—Prednisone—systemic scleroderma	0.000191	0.000366	CcSEcCtD
Vinorelbine—Dermatitis—Prednisone—systemic scleroderma	0.000191	0.000366	CcSEcCtD
Vinorelbine—Headache—Prednisone—systemic scleroderma	0.00019	0.000364	CcSEcCtD
Vinorelbine—Hypersensitivity—Methotrexate—systemic scleroderma	0.000186	0.000357	CcSEcCtD
Vinorelbine—Asthenia—Methotrexate—systemic scleroderma	0.000181	0.000348	CcSEcCtD
Vinorelbine—Nausea—Prednisone—systemic scleroderma	0.00018	0.000345	CcSEcCtD
Vinorelbine—Pruritus—Methotrexate—systemic scleroderma	0.000179	0.000343	CcSEcCtD
Vinorelbine—Diarrhoea—Methotrexate—systemic scleroderma	0.000173	0.000332	CcSEcCtD
Vinorelbine—Dizziness—Methotrexate—systemic scleroderma	0.000167	0.000321	CcSEcCtD
Vinorelbine—Vomiting—Methotrexate—systemic scleroderma	0.000161	0.000308	CcSEcCtD
Vinorelbine—Rash—Methotrexate—systemic scleroderma	0.000159	0.000306	CcSEcCtD
Vinorelbine—Dermatitis—Methotrexate—systemic scleroderma	0.000159	0.000306	CcSEcCtD
Vinorelbine—Headache—Methotrexate—systemic scleroderma	0.000158	0.000304	CcSEcCtD
Vinorelbine—Nausea—Methotrexate—systemic scleroderma	0.00015	0.000288	CcSEcCtD
